injectable glp 1 agonist The Latest on GLP-1s | Lexington Medical Center Blog GLP-1 Weight Loss Options |

Description

It targets hormones GLP-1 and GIP to control appetite, leading to significant weight loss

D., Hansen, T., & Bain, S

[DOI] [PMC free article] [PubMed] [Google Scholar] 209.Castellana M., Cignarelli A., Brescia F., Perrini S., Natalicchio A., Laviola L

The queries for the articles about the gut-liver axis: ((GLP-1RAs[Title/Abstract]) OR (GLP-1R agonists[Title/Abstract]) OR (GLP-1 receptor agonists[Title/Abstract]) OR (GLP-1 receptor[Title/Abstract])) AND ((liver[Title/Abstract]) OR (hepatic[Title/Abstract]) OR (HCC[Title/Abstract])) AND (microbiota[Title/Abstract])

DOI: Published: Publisher Name: Springer, Cham Print ISBN: 978-3-319-45014-8 Online ISBN: 978-3-319-45015-5 eBook Packages: MedicineReference Module Medicine

New GLP1-based multi-agonist therapies seem to be substantially more effective than older GLP1R agonists in reducing body weight but their safety requires ongoing scrutiny in trials assessing outcomes in individuals with obesity